Sinclair Pharma (XPAR:SPH) FCF Margin % : -43.65% (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sinclair Pharma's Free Cash Flow for the six months ended in Jun. 2018 was €-10.56 Mil. Sinclair Pharma's Revenue for the six months ended in Jun. 2018 was €24.20 Mil. Therefore, Sinclair Pharma's FCF Margin % for the quarter that ended in Jun. 2018 was -43.65%.

As of today, Sinclair Pharma's current FCF Yield % is -6.96%.

The historical rank and industry rank for Sinclair Pharma's FCF Margin % or its related term are showing as below:

XPAR:SPH' s FCF Margin % Range Over the Past 10 Years
Min: -24.67 Med: 0 Max: 0
Current: -24.67

XPAR:SPH's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.025 vs XPAR:SPH: -24.67

Sinclair Pharma FCF Margin % Historical Data

The historical data trend for Sinclair Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma FCF Margin % Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

FCF Margin %

Get a 7-Day Free Trial

0.01

-13.42

-13.37

7.27

-30.32

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
FCF Margin %	Get a 7-Day Free Trial															-101.02	-54.54	-57.66	-8.61	-43.65

Competitive Comparison of Sinclair Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's FCF Margin % falls into.

Sinclair Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sinclair Pharma's FCF Margin for the fiscal year that ended in Dec. 2017 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2017 )	/	Revenue (A: Dec. 2017 )
	=	-15.56	/	51.312
	=	-30.32 %

Sinclair Pharma's FCF Margin for the quarter that ended in Jun. 2018 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2018 )	/	Revenue (Q: Jun. 2018 )
	=	-10.561	/	24.196
	=	-43.65 %

Sinclair Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.